EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) fell 24.6% during trading on Friday . The stock traded as low as $0.3196 and last traded at $0.3196. 20,000 shares were traded during mid-day trading, a decline of 8% from the average session volume of 21,810 shares. The stock had previously closed at $0.4237.
EKF Diagnostics Stock Down 24.6%
The firm’s 50 day moving average is $4,295.36 and its two-hundred day moving average is $1,491.68.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Further Reading
- Five stocks we like better than EKF Diagnostics
- Most Volatile Stocks, What Investors Need to Know
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Growth Stocks: What They Are, Examples and How to Invest
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
